雅克袭击:改变印度性结肠炎的管理
Arshdeep Singh1, Arshia Bhardwaj1, Vandana Midha2
1Department of Gastroenterology, Dayanand Medical College and Hospital, Ludhiana, India.
类激酶 (JAK) 抑制剂,如托法西提尼布,正在改变印度的性结肠炎 (UC) 管理. 口服托法西提尼布提供了有效的治疗选择,改善了不同UC患者群体的治疗结果并减少了类固醇依赖.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 包括性结肠炎 (UC) 在内的炎症性肠病 (IBD) 在印度正在上升.
- 传统疗法 (皮质类固醇,硫素) 在有效性和可访问性方面存在局限性.
- 在资源有限的环境中需要先进的疗法.
研究的目的:
- 审查Janus激酶 (JAK) 抑制剂,特别是托法西提尼布在印度UC管理中的作用.
- 评估托法西提尼布对治疗目标和现实世界的实施的影响.
- 突出印度医疗保健背景下托法西提尼布的优势.
主要方法:
- 对印度UC患者的托法西提尼布现有文献和现实世界的证据的审查.
- 对托法西提尼布的药理动力学特性,服用途径和配方的分析.
- 对各种UC表型和缓解终点的临床实用性的评估.
主要成果:
- 托法西提尼布在不同UC表型 (耐火性,严重,直肠炎,老年发病) 中显示出显著的临床效用.
- 口服,快速作用和具有成本效益的通用配方促进了采用.
- 现实世界的数据显示,皮质类固醇依赖性降低,并实现更深的缓解,包括组织学愈合.
结论:
- 托法西提尼布代表了印度UC管理的范式转变.
- 它的有效性,安全性,可访问性和易用性解决了先进疗法的障碍.
- 托法西提尼布使印度的治疗策略与国际护理标准保持一致.
更多相关视频
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
08:34Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
